![John Dunn](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
John Dunn
Conseiller Juridique Général chez
CALCIMEDICA, INC.
Profil
Mr. John M.
Dunn is a General Counsel at CalciMedica, Inc. He is on the Board of Directors at Agility Clinical, Inc., CONNECT and The University of Wyoming Foundation.
Mr. Dunn was previously employed as an Independent Director by Acer Therapeutics, Inc., a Secretary & General Counsel by Vital Therapies, Inc., an Executive Vice President by Biogen Idec, Inc., an Executive Vice President by Biogen Idec New Ventures, Inc., a Secretary, Senior VP-Legal & Compliance by IDEC Pharmaceuticals Corp., and a Partner by Pillsbury Winthrop LLP.
He also served on the board at Sharp HealthCare, Opexa Therapeutics, Inc., Acer Therapeutics, Inc. /Old/ and Biocom, Inc. He received his undergraduate degree from the University of Wyoming and a graduate degree from the University of Wyoming.
Postes actifs de John Dunn
| Sociétés | Poste | Début |
|---|---|---|
| CALCIMEDICA, INC. | Conseiller Juridique Général | 20/03/2023 |
Agility Clinical, Inc.
 Agility Clinical, Inc. Miscellaneous Commercial ServicesCommercial Services Operates as a specialty consulting and clinical research organization | Directeur/Membre du Conseil | - |
CONNECT
 CONNECT Miscellaneous Commercial ServicesCommercial Services Offers education, networking and recognitions services | Directeur/Membre du Conseil | - |
The University of Wyoming Foundation
 The University of Wyoming Foundation Investment Trusts/Mutual FundsMiscellaneous Foundation | Directeur/Membre du Conseil | - |
Anciens postes connus de John Dunn
| Sociétés | Poste | Fin |
|---|---|---|
| ACER THERAPEUTICS INC. | Directeur/Membre du Conseil | 17/11/2023 |
Vital Therapies, Inc.
 Vital Therapies, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biotherapeutic company focused on developing a cell-based therapy | Conseiller Juridique Général | 12/04/2019 |
| BIOGEN INC. | Corporate Officer/Principal | 01/01/2012 |
Biogen Idec New Ventures, Inc.
 Biogen Idec New Ventures, Inc. Investment ManagersFinance Biogen Idec New Ventures' strategy is to select investments in companies developing innovative human therapeutic products or technologies that will drive product discovery and development more efficiently. Their specific areas of interest are companies in Biogen Idec's current therapeutic areas of neurology, oncology and immunology/inflammation, but they also seek opportunities outside these areas that fit their strategies for longer-term growth. The firm invests at all stages of development; most of their investments are in early-stage companies. They also look for investment opportunities where they can leverage their parent's resources and scientific and development expertise to support these investments. | Corporate Officer/Principal | 31/12/2008 |
IDEC Pharmaceuticals Corp.
 IDEC Pharmaceuticals Corp. Pharmaceuticals: MajorHealth Technology Discovers, develops and commercializes targeted immunotherapies for the treatment of cancer and autoimmune diseases | Compliance Officer | 01/11/2003 |
Formation de John Dunn
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
68
Relations au 1er degré
15
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 15 |
|---|---|
Biogen, Inc.
 Biogen, Inc. Pharmaceuticals: MajorHealth Technology Manufactures and markets therapies for neurological and neurodegenerative diseases | Health Technology |
Agility Clinical, Inc.
Agility Clinical, Inc. Miscellaneous Commercial ServicesCommercial Services Operates as a specialty consulting and clinical research organization | Commercial Services |
Acer Therapeutics, Inc. /Old/
 Acer Therapeutics, Inc. /Old/ Pharmaceuticals: MajorHealth Technology Develops therapeutics for the treatment of orphan diseases. | Health Technology |
Pillsbury Winthrop LLP
 Pillsbury Winthrop LLP Miscellaneous Commercial ServicesCommercial Services Provides legal services | Commercial Services |
IDEC Pharmaceuticals Corp.
IDEC Pharmaceuticals Corp. Pharmaceuticals: MajorHealth Technology Discovers, develops and commercializes targeted immunotherapies for the treatment of cancer and autoimmune diseases | Health Technology |
Vital Therapies, Inc.
Vital Therapies, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biotherapeutic company focused on developing a cell-based therapy | Health Technology |
University of Wyoming
 University of Wyoming Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
BIOCOM
 BIOCOM Miscellaneous Commercial ServicesCommercial Services Provides scientific and technological services | Commercial Services |
Sharp HealthCare
 Sharp HealthCare Hospital/Nursing ManagementHealth Services Operates acute care and specialty hospitals | Health Services |
Biogen Idec New Ventures, Inc.
Biogen Idec New Ventures, Inc. Investment ManagersFinance Biogen Idec New Ventures' strategy is to select investments in companies developing innovative human therapeutic products or technologies that will drive product discovery and development more efficiently. Their specific areas of interest are companies in Biogen Idec's current therapeutic areas of neurology, oncology and immunology/inflammation, but they also seek opportunities outside these areas that fit their strategies for longer-term growth. The firm invests at all stages of development; most of their investments are in early-stage companies. They also look for investment opportunities where they can leverage their parent's resources and scientific and development expertise to support these investments. | Finance |
Opexa Therapeutics, Inc.
 Opexa Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops autologous personalized cell therapies for the treatment of various diseases. | Health Technology |
CONNECT
CONNECT Miscellaneous Commercial ServicesCommercial Services Offers education, networking and recognitions services | Commercial Services |
The University of Wyoming Foundation
The University of Wyoming Foundation Investment Trusts/Mutual FundsMiscellaneous Foundation | Miscellaneous |
Acer Therapeutics, Inc.
 Acer Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as a pharmaceutical company that develops and commercializes therapies for serious rare and life-threatening diseases | Health Technology |
CalciMedica, Inc.
 CalciMedica, Inc. BiotechnologyHealth Technology Operates as a clinical-stage biopharmaceutical company | Health Technology |
